Corcept Therapeutics CORT
NASDAQ CORT
$75.03 +2.26 (+3.11%)
At close: Nov 9, 2026 · 4:00 PM EST

Corcept Therapeutics (CORT) Depreciation & Amortization (CF) (2010 - 2026)

Updated

Corcept Therapeutics' Depreciation & Amortization (CF) came in at $1.03 million for Q3 2026, up 115.1% from $477,000 a year earlier and up 18.9% from the prior quarter.

Analysis

Corcept Therapeutics (CORT) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends

Over the trailing twelve months to Sep 30, 2026, Corcept Therapeutics reported Depreciation & Amortization (CF) of $2.23 million, up 31.9% year-over-year; for FY2025, it was $1.15 million, up 44.5% from FY2024.

  • Depreciation & Amortization (CF) carries a five-year compound annual growth rate of 17.0% (FY2020 to FY2025).
  • Going back by year, Depreciation & Amortization (CF) was $795,000 in FY2024 (-23.7%), $1.04 million in FY2023 (-17.2%), $1.26 million in FY2022 (+17.4%) and $1.07 million in FY2021 (+104.2%).
  • The Q3 2026 figure represents the highest quarterly Depreciation & Amortization (CF) since Q2 2021.
  • Year-over-year, Depreciation & Amortization (CF) has increased for three consecutive quarters, with growth averaging 158.9% over the last seven quarters.
  • The fastest year-over-year change in Depreciation & Amortization (CF) over five years came in Q2 2025 (growth of 517.1%), and the weakest in Q2 2022 (a decline of 94.8%).
  • Business Quant data shows CORT's Depreciation & Amortization (CF) at $863,000 (Q2 2026), $598,000 (Q1 2026) and -$259,000 (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn 545.00 Mn
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn 2.12 Bn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn 192.00 Mn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn 726.00 Mn
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn 1.61 Bn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn 1.12 Bn
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn 132.00 Mn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn 1.58 Bn
10 Corcept Therapeutics 7.99 Bn 6.60 Bn 335.86 Mn 1.03 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 1.03 Mn
Jun 30, 2026 863,000.00
Mar 31, 2026 598,000.00
Dec 31, 2025 289,000.00
Sep 30, 2025 -71,000.00
Jun 30, 2025 469,000.00
Mar 31, 2025 462,000.00
Dec 31, 2024 281,000.00
Sep 30, 2024 318,000.00
Jun 30, 2024 76,000.00
Mar 31, 2024 120,000.00
Dec 31, 2023 214,000.00
Sep 30, 2023 232,000.00
Jun 30, 2023 424,000.00
Mar 31, 2023 172,000.00
Dec 31, 2022 660,000.00
Sep 30, 2022 195,000.00
Jun 30, 2022 116,000.00
Mar 31, 2022 288,000.00
Dec 31, 2021 289,000.00
API Access

Corcept Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=CORT&period=max&api_key=YOUR_API_KEY